首页
外语
计算机
考研
公务员
职业资格
财经
工程
司法
医学
专升本
自考
实用职业技能
登录
考研
Read the following text and match each of the numbered items in the left column to its corresponding information in the right co
Read the following text and match each of the numbered items in the left column to its corresponding information in the right co
admin
2022-12-09
157
问题
Read the following text and match each of the numbered items in the left column to its corresponding information in the right column. There are two extra choices in the right column. Mark your answers on the ANSWER SHEET.
In a state-of-the-art clean room, a scientist clad in a full-body containment suit, a hair net and blue gloves is preparing some printing cartridges—filled not with ink but a viscous milky liquid. Next to her sits a computer connected to a machine that resembles a large ice-cream dispenser, except that each of its two nozzles is made of a syringe with a long needle. Once the scientist clicks on the "run program" button, the needles squeeze not a vanilla or chocolate flavoured treat, but a paste of living cells.
Forty minutes later, the task is finished. Depending on the choice of bioink and printing pattern, the result could have been any number of three-dimensional biological structures. In this case, it is a strand of living lung tissue about 4cm in length and containing about 50m cells.
Since its start in 2007, researchers at San Diego-based Organovo have experimented with printing a wide variety of tissues, including bits of lung, kidney and heart muscle. Now the world’s first publicly traded 3D bioprinting company is gearing up for production. In January samples of its first product—slivers of human liver tissue—were delivered to an outside laboratory for testing. These are printed in sets of 24 and take about 30 minutes to produce, says Keith Murphy, the firm’s chief executive. Later this year Organovo aims to begin commercial sales.
Each set consists of a plate with 24 wells containing a piece of liver tissue 3mm square and 0.5mm deep. Although prices have not been fixed, a set of tissues like this can sell for $2,000 or more for laboratory use. It might seem expensive, but it could save pharmaceutical companies a lot of money. This is because Organovo’s research indicates that the slivers of liver respond to drugs in many ways like a fully grown human liver would. If this is confirmed by outside testing, researchers could use the printed tissues to test the toxicity of new drugs before deciding whether to embark on expensive clinical trials with patients.
The invention of 3D printing in the 1980s provided a technology now used to manufacture everything from aircraft parts to prosthetic limbs. But the promise of 3D bioprinting is even larger: to create human tissues—layer by layer—for research, drug development and testing, and ultimately as replacement organs, such as a kidney or pancreas, for patients desperately in need of a transplant. Bioprinted organs could be made from patients’ own cells and thus would not be rejected by their immune systems. They could also be manufactured on demand.
At present only a handful of companies are trying to commercialize the production of bioprinted tissues. But Thomas Boland, an early pioneer in the field, says that plenty of others are interested and estimates that about 80 teams at research institutions around the world are now trying to print small pieces of tissues as varied as skin, cartilage, blood vessels, liver, lung and heart. "It’s a wonderful technology to build three-dimensional biological structures," says Gabor Forgacs, who co-founded Organovo in 2007 and was the company’s scientific mastermind.
[A] would be made on the need of the market.
[B] said that bioprinting was a wonderful technology.
[C] could be made from the cells of patients’ relatives.
[D] claimed that it took a short time to print the tissues.
[E] showed that the printed tissues were similar to real tissues.
[F] reckoned that bioprinting appealed to a majority of companies.
[G] conducted a large number of experimental studies of bioprinting.
Organovo’s research
选项
答案
E
解析
根据Organovo’s research定位至第四段。第四句This is because Organovo’s research indicates that the slivers of liver respond to drugs in many ways like a fully grown human liver would (这是因为,Organovo的研究表明,打印出的肝组织切片在许多方面对药物的反应与发育完全的人类肝脏一致)。与该句表述意义相近的是选项E,表明打印出来的人体组织与真正的人体组织相似,这与原文“打印出的肝组织切片在许多方面对药物的反应与发育完全的人类肝脏一致”基本吻合。故本题答案为E。
转载请注明原文地址:https://kaotiyun.com/show/lQMD777K
0
考研英语二
相关试题推荐
Actually,IhadreadonebookinEnglish,whenIwasinmiddleschool.Butitwasforgettable.Thistimearound,Iwasinamore
Americahaslongbeenresistanttoadequatepovertypoliciesbecauseofitsstrongstrainofthinkingthatthepoorareresponsi
Everyonewantstobeauthentic.Youwanttobetruetoyourself,notaslavishfollowerofsocialexpectations.Youwantto"liv
SelectiveNewYorkCitypublichighschoolsaresupposedtomakeiteasyforfamiliestoseetheirdetailedadmissioncriteria,
Thinnerisn’talwaysbetter.Anumberofstudieshave【C1】________thatnormal-weightpeopleareinfactathigherriskofsomedi
Onceusedlargelyinlawenforcement,bodyworncameras,orbodycams,havebecomederigueurforemployeeswhomeetthepublicat
Fordecadesthemarketforexpensiveheadphoneswasmainlylimitedtohi-fifans.But【C1】________theboxystereosysteminthec
WhydoweneedtheEnglishmajor?The【C1】________isineverymouth—or,atleast,isdiscussedextensivelyincolumnsand【C2】____
WhydoweneedtheEnglishmajor?The【C1】________isineverymouth—or,atleast,isdiscussedextensivelyincolumnsand【C2】____
WhydoweneedtheEnglishmajor?The【C1】________isineverymouth—or,atleast,isdiscussedextensivelyincolumnsand【C2】____
随机试题
某出版社的编辑小刘手中有一篇有关财务软件应用的书稿“Word素材.docx”,请按下列要求完成书稿编排工作。目录与书稿的页码分别独立编排,目录页码使用大写罗马数字(Ⅰ,Ⅱ,Ⅲ,……),书稿页码使用阿拉伯数字(1,2,3,……)且各章节间连续编码。除目录
治疗牛的后躯麻痹时,应选用的中枢兴奋药是
A糖衣片B肠溶衣片C泡腾片D舌下片E控缓释片对于味道较苦的中药,可制成
以下关于浅埋暗挖法“十八字”原则说法正确的是()。
金融期权交易中进行流通转让的对象是( )。
依据指标值的时间特点,绝对数时间序列分为()。
A集团股份有限公司(以下简称A集团)成立于2005年,发展至今,已成为国内较大的综合类商城,主营是综合电器、电子、汽车、百货、办公耗材、文体用品、母婴用品、粮油食品、化妆品、体育器材的销售,另包括自营品牌产品的设计、生产与配送。A集团具备进出口经营权,其所
对决策者来说,要使决策达到最优必须要做到()。
文化例外指在国际自由贸易体制下,基于文化商品和服务的双重属性,而将文化商品排除在贸易自由化的谈判之外,不适用有关的自由贸易法律规则。根据上述定义,下列属于文化例外的是:
Somemoderncitiesareusuallyfamousforpeoplewholiveaverylongtime.
最新回复
(
0
)